DENVER--(BUSINESS WIRE)--Less than 30 days after the Sapheneia Scannerside partnership announcement, the two companies bring the first single-source solution for CMS Lung Screening, ClearCT™ Lung to market. On November 10, 2014, the U.S. Centers for Medicare and Medicaid Services (CMS) approved CT lung cancer screening for Medicare recipients. Part of the radiology imaging center eligibility criteria include Low Dose Computed Tomography (LDCT) of less than 1.5 mSv and the collection and submiss
| < Prev | Next > |
|---|
